Table 2.
IgG doses and intervals.
| Reference | Patients (n) | Mean Ig dose (g/kg) | Mean interval (weeks) | Patients (%) receiving IgG at interval ≤ 14 days |
|---|---|---|---|---|
| Lunn et al., 2016 | CIDP 39 | 1.4 | 4.3 | 17 |
| MMN 24 | ||||
| Kuitwaard et al., 2013 | CIDP 25 | 0.43 | 2.4 | 60 |
| Rajabally et al., 2006, * | CIDP 15 | 0.69* | 6.9 | 13 |
| Broyles et al., 2013 | CIDP 31 | 0.87 | 4.0 | 25 |
CIDP, chronic inflammatory demyelinating polyneuropathy; IgG, immunoglobulin G; MMN, multifocal motor neuropathy; SEM, standard error of the mean.
Note that common criteria for defining endpoints and/or selecting maintenance doses were not employed across the different studies.
*
Final or lowest dose per course.